土耳其痴呆症可修改风险因素的人口可归因部分
Bugra Taygun Gulle1, Busra Tozduman2
1Izmir Provincial Health Directorate, Public Health Services Department, Izmir, Turkey.
Dementia (London, England)
|June 29, 2025
概括
土耳其近一半的痴呆病例是可以预防的. 关键因素包括身体不活动,社会隔离和低教育程度,女性的风险更高. 有针对性的干预措施可以减少痴呆症的患病率.
科学领域:
- 公共卫生 公共卫生
- 流行病学 流行病学
- 老年学是一门学科.
背景情况:
- 痴呆症在全球影响着5500万,可修改的风险因素有着显著的贡献.
- "柳叶刀委员会"的框架提供了一个关于痴呆风险的全球视角.
- 之前没有任何研究将这种框架应用于土耳其人口.
研究的目的:
- 估计土耳其14种可修改的痴呆风险因素的人口归因分数 (PAF).
- 使用更新的2024年兰塞特委员会框架进行分析.
- 在土耳其为预防痴呆症提供有针对性的公共卫生战略的信息.
主要方法:
- 采用了来自2022年土耳其健康调查的数据,这是一个具有全国代表性的数据集.
- 计算了PAF,使用了从元分析和"柳叶刀"委员会报告中获得的相对风险.
- 应用主要组件分析来管理风险因素之间的相互关联.
主要成果:
- 据估计,土耳其的PAF总权重为49.9%,这表明可预防性很大.
- 身体不活动,社会隔离和低教育水平成为不同生命阶段的主要风险因素.
- 女性的PAF (54.2%) 比男性 (44.3%) 高,与身体不活动,抑郁和社会隔离有关.
结论:
- 在土耳其,大约一半的痴呆病例归因于可修改的风险因素.
- 针对身体不活动和社会孤立的文化定制和性别敏感的干预措施至关重要.
- 调查结果强调了通过公共卫生倡议显著减少痴呆症负担的潜力.
相关概念视频
01:30Dementia
174
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
174
01:08Prevalence and Incidence
833
In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
833
01:26Alzheimer's Disease: Overview
678
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
678
01:26Atherosclerosis III: Management
41
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
41
01:30Coronary Artery Disease I: Introduction
67
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
67
01:49Probability Laws
41.9K
Overview
41.9K